Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Vessel Anomalies | 10 | 2024 | 308 | 3.520 |
Why?
|
Venous Thromboembolism | 18 | 2022 | 1883 | 3.160 |
Why?
|
Benzamides | 15 | 2021 | 1379 | 2.700 |
Why?
|
Enoxaparin | 13 | 2022 | 391 | 2.620 |
Why?
|
Vascular Diseases | 10 | 2024 | 1162 | 2.440 |
Why?
|
Pyridines | 16 | 2021 | 2894 | 1.770 |
Why?
|
Anticoagulants | 22 | 2022 | 4852 | 1.740 |
Why?
|
Forecasting | 4 | 2024 | 2945 | 1.590 |
Why?
|
Venous Thrombosis | 7 | 2022 | 1323 | 1.430 |
Why?
|
Life Expectancy | 4 | 2024 | 1248 | 1.400 |
Why?
|
Acute Coronary Syndrome | 9 | 2023 | 2194 | 1.310 |
Why?
|
Apolipoprotein A-I | 7 | 2024 | 305 | 1.100 |
Why?
|
Inpatients | 5 | 2019 | 2566 | 1.080 |
Why?
|
Fibromuscular Dysplasia | 3 | 2024 | 55 | 1.020 |
Why?
|
Pulmonary Embolism | 5 | 2022 | 2599 | 0.990 |
Why?
|
Hemorrhage | 11 | 2019 | 3467 | 0.960 |
Why?
|
Fibrinolytic Agents | 4 | 2019 | 2080 | 0.940 |
Why?
|
Takotsubo Cardiomyopathy | 3 | 2020 | 125 | 0.920 |
Why?
|
Erythrocyte Indices | 2 | 2022 | 143 | 0.920 |
Why?
|
Birth Rate | 1 | 2024 | 168 | 0.820 |
Why?
|
Myocardial Infarction | 14 | 2024 | 11519 | 0.760 |
Why?
|
Vitamin K | 3 | 2018 | 314 | 0.750 |
Why?
|
Atrial Fibrillation | 6 | 2019 | 5176 | 0.750 |
Why?
|
Stillbirth | 1 | 2024 | 381 | 0.750 |
Why?
|
Stroke | 12 | 2024 | 9755 | 0.710 |
Why?
|
Fibrin Fibrinogen Degradation Products | 6 | 2022 | 425 | 0.710 |
Why?
|
Hospitalization | 8 | 2022 | 10840 | 0.690 |
Why?
|
Diabetic Neuropathies | 1 | 2024 | 410 | 0.690 |
Why?
|
Azithromycin | 1 | 2021 | 201 | 0.680 |
Why?
|
Risk Factors | 33 | 2024 | 74944 | 0.670 |
Why?
|
Atherosclerosis | 5 | 2022 | 3433 | 0.670 |
Why?
|
Myocardial Bridging | 1 | 2019 | 10 | 0.660 |
Why?
|
Photoplethysmography | 1 | 2019 | 66 | 0.650 |
Why?
|
Coronary Vessels | 6 | 2024 | 3124 | 0.640 |
Why?
|
Coronary Angiography | 7 | 2024 | 4541 | 0.620 |
Why?
|
Hypoalbuminemia | 1 | 2018 | 90 | 0.580 |
Why?
|
Hydroxychloroquine | 1 | 2021 | 426 | 0.560 |
Why?
|
Acute Disease | 6 | 2018 | 7243 | 0.530 |
Why?
|
Overweight | 2 | 2024 | 2448 | 0.520 |
Why?
|
Coronary Thrombosis | 1 | 2018 | 440 | 0.500 |
Why?
|
Warfarin | 3 | 2018 | 1493 | 0.500 |
Why?
|
Communicable Diseases | 1 | 2024 | 874 | 0.500 |
Why?
|
Gestational Age | 1 | 2024 | 3621 | 0.500 |
Why?
|
Quality-Adjusted Life Years | 4 | 2024 | 1741 | 0.490 |
Why?
|
Models, Cardiovascular | 1 | 2020 | 981 | 0.490 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1134 | 0.450 |
Why?
|
Albuminuria | 1 | 2017 | 658 | 0.440 |
Why?
|
Humans | 81 | 2024 | 768166 | 0.440 |
Why?
|
Eosinophils | 1 | 2018 | 952 | 0.430 |
Why?
|
Migraine Disorders | 2 | 2024 | 1713 | 0.430 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6568 | 0.400 |
Why?
|
Vitamins | 1 | 2020 | 1638 | 0.390 |
Why?
|
Peripheral Arterial Disease | 1 | 2023 | 1304 | 0.390 |
Why?
|
Female | 49 | 2024 | 397192 | 0.390 |
Why?
|
Postoperative Care | 1 | 2018 | 1480 | 0.380 |
Why?
|
Premature Birth | 1 | 2024 | 1829 | 0.380 |
Why?
|
Aged | 32 | 2024 | 171504 | 0.380 |
Why?
|
Erythrocytes | 1 | 2021 | 2418 | 0.380 |
Why?
|
Middle Aged | 32 | 2024 | 223492 | 0.370 |
Why?
|
Male | 45 | 2024 | 364719 | 0.360 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 973 | 0.360 |
Why?
|
Coronary Artery Bypass | 1 | 2020 | 2191 | 0.360 |
Why?
|
Time Factors | 10 | 2020 | 40218 | 0.340 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 10399 | 0.340 |
Why?
|
Lower Extremity | 1 | 2017 | 1216 | 0.330 |
Why?
|
Lipoproteins, HDL | 5 | 2024 | 682 | 0.330 |
Why?
|
Demography | 2 | 2024 | 1641 | 0.320 |
Why?
|
Antiviral Agents | 1 | 2021 | 3073 | 0.310 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1751 | 0.310 |
Why?
|
Anemia | 1 | 2018 | 1514 | 0.310 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 3251 | 0.300 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1805 | 0.300 |
Why?
|
Health Status | 2 | 2020 | 4091 | 0.300 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4860 | 0.300 |
Why?
|
Double-Blind Method | 10 | 2024 | 12465 | 0.290 |
Why?
|
Smoking | 1 | 2024 | 9092 | 0.290 |
Why?
|
Dietary Supplements | 1 | 2020 | 3445 | 0.280 |
Why?
|
Electrocardiography | 2 | 2019 | 6412 | 0.280 |
Why?
|
Risk Assessment | 8 | 2024 | 24315 | 0.280 |
Why?
|
Young Adult | 10 | 2024 | 60066 | 0.270 |
Why?
|
Heart Transplantation | 1 | 2020 | 3301 | 0.270 |
Why?
|
Age Distribution | 2 | 2024 | 2873 | 0.260 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15662 | 0.250 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2022 | 879 | 0.250 |
Why?
|
Cholesterol, LDL | 3 | 2024 | 2403 | 0.250 |
Why?
|
Biomedical Research | 2 | 2017 | 3463 | 0.240 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2020 | 2763 | 0.240 |
Why?
|
Peptide Fragments | 1 | 2017 | 5151 | 0.240 |
Why?
|
Hypertension | 2 | 2022 | 8616 | 0.240 |
Why?
|
Obesity | 2 | 2024 | 13090 | 0.240 |
Why?
|
Adult | 16 | 2024 | 223646 | 0.230 |
Why?
|
Prevalence | 4 | 2024 | 15869 | 0.230 |
Why?
|
Hemoglobins | 2 | 2022 | 1531 | 0.220 |
Why?
|
Risk | 5 | 2018 | 9613 | 0.220 |
Why?
|
Patient Readmission | 1 | 2018 | 3288 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9419 | 0.220 |
Why?
|
Stents | 4 | 2020 | 3195 | 0.210 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59629 | 0.210 |
Why?
|
Thienopyridines | 1 | 2022 | 9 | 0.210 |
Why?
|
Mortality | 2 | 2024 | 2911 | 0.200 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.190 |
Why?
|
Scleroderma, Systemic | 1 | 2005 | 346 | 0.190 |
Why?
|
Cerebral Hemorrhage | 2 | 2022 | 2655 | 0.180 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 345 | 0.170 |
Why?
|
Prognosis | 5 | 2022 | 30010 | 0.170 |
Why?
|
Chloroquine | 1 | 2021 | 276 | 0.170 |
Why?
|
Incidence | 4 | 2024 | 21538 | 0.170 |
Why?
|
Intracranial Hypertension | 1 | 2022 | 191 | 0.170 |
Why?
|
Infant, Newborn | 3 | 2024 | 26422 | 0.170 |
Why?
|
Infant Mortality | 1 | 2024 | 752 | 0.170 |
Why?
|
Infusions, Intravenous | 4 | 2024 | 2230 | 0.160 |
Why?
|
Treatment Outcome | 12 | 2024 | 65371 | 0.160 |
Why?
|
Fertility | 1 | 2024 | 771 | 0.160 |
Why?
|
Adolescent | 5 | 2024 | 89169 | 0.160 |
Why?
|
Coronary Vasospasm | 1 | 2019 | 81 | 0.160 |
Why?
|
Inflammation | 1 | 2018 | 10873 | 0.150 |
Why?
|
Leukocytosis | 1 | 2019 | 251 | 0.150 |
Why?
|
Malocclusion, Angle Class III | 1 | 2018 | 38 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6316 | 0.150 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2017 | 30 | 0.150 |
Why?
|
Heparin | 2 | 2022 | 1636 | 0.150 |
Why?
|
Sex Distribution | 2 | 2020 | 2278 | 0.150 |
Why?
|
Osteotomy, Le Fort | 1 | 2018 | 94 | 0.150 |
Why?
|
Immobilization | 1 | 2018 | 229 | 0.140 |
Why?
|
Blood Coagulation Disorders | 1 | 2021 | 350 | 0.140 |
Why?
|
Hematoma | 1 | 2022 | 766 | 0.140 |
Why?
|
Child, Preschool | 3 | 2024 | 42669 | 0.140 |
Why?
|
Sclera | 1 | 2018 | 189 | 0.140 |
Why?
|
Body Mass Index | 3 | 2024 | 13053 | 0.140 |
Why?
|
Connective Tissue Diseases | 1 | 2020 | 285 | 0.140 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 3740 | 0.130 |
Why?
|
Troponin T | 1 | 2021 | 787 | 0.130 |
Why?
|
Databases, Factual | 2 | 2023 | 8080 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2022 | 1243 | 0.130 |
Why?
|
Esthetics | 1 | 2018 | 328 | 0.130 |
Why?
|
Antidotes | 1 | 2017 | 138 | 0.130 |
Why?
|
Coronary Occlusion | 1 | 2019 | 306 | 0.130 |
Why?
|
Interleukins | 1 | 2021 | 796 | 0.130 |
Why?
|
Factor Xa | 1 | 2017 | 166 | 0.130 |
Why?
|
Inflammasomes | 1 | 2021 | 540 | 0.130 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2016 | 42 | 0.130 |
Why?
|
Antithrombins | 1 | 2018 | 294 | 0.130 |
Why?
|
Disease Progression | 2 | 2024 | 13671 | 0.130 |
Why?
|
Creatine Kinase, MB Form | 1 | 2016 | 202 | 0.130 |
Why?
|
Antirheumatic Agents | 1 | 2005 | 1381 | 0.120 |
Why?
|
Serum Albumin | 1 | 2018 | 677 | 0.120 |
Why?
|
Capillaries | 1 | 2018 | 755 | 0.120 |
Why?
|
Maxilla | 1 | 2018 | 488 | 0.120 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 493 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 592 | 0.120 |
Why?
|
Thrombosis | 3 | 2021 | 2957 | 0.120 |
Why?
|
Stress, Mechanical | 1 | 2020 | 1676 | 0.120 |
Why?
|
Income | 1 | 2023 | 1878 | 0.120 |
Why?
|
Registries | 4 | 2024 | 8375 | 0.120 |
Why?
|
Causality | 1 | 2020 | 1254 | 0.110 |
Why?
|
Recurrence | 3 | 2024 | 8509 | 0.110 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2021 | 1024 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12252 | 0.110 |
Why?
|
Veins | 1 | 2017 | 769 | 0.110 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1737 | 0.110 |
Why?
|
Administration, Oral | 2 | 2018 | 4030 | 0.110 |
Why?
|
Heart Failure | 1 | 2017 | 11879 | 0.110 |
Why?
|
Pandemics | 2 | 2024 | 8748 | 0.100 |
Why?
|
Conflict of Interest | 1 | 2017 | 556 | 0.100 |
Why?
|
Pyridones | 1 | 2017 | 819 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2018 | 1027 | 0.100 |
Why?
|
Troponin I | 1 | 2016 | 662 | 0.100 |
Why?
|
Child | 3 | 2024 | 80917 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1551 | 0.090 |
Why?
|
Pregnancy | 2 | 2024 | 30256 | 0.090 |
Why?
|
Oligopeptides | 1 | 2016 | 1194 | 0.090 |
Why?
|
Endothelium, Vascular | 2 | 2021 | 4427 | 0.090 |
Why?
|
Cardiovascular System | 1 | 2018 | 841 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2726 | 0.080 |
Why?
|
Heart Diseases | 2 | 2021 | 2819 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2020 | 2138 | 0.080 |
Why?
|
Cholesterol | 3 | 2023 | 2914 | 0.080 |
Why?
|
Critical Illness | 2 | 2019 | 2756 | 0.080 |
Why?
|
Myocardium | 2 | 2019 | 4788 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5315 | 0.080 |
Why?
|
Antioxidants | 1 | 2016 | 1673 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2021 | 3007 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39348 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12077 | 0.070 |
Why?
|
Secondary Prevention | 2 | 2024 | 1474 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6514 | 0.070 |
Why?
|
Pyrazoles | 1 | 2017 | 2028 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5349 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3858 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3135 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3573 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1456 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4640 | 0.060 |
Why?
|
Research Design | 1 | 2022 | 6211 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1820 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2024 | 6526 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2665 | 0.060 |
Why?
|
Societies, Medical | 1 | 2017 | 3968 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6498 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2022 | 81762 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 6004 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2016 | 3841 | 0.060 |
Why?
|
Mass Screening | 1 | 2019 | 5458 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 12543 | 0.050 |
Why?
|
Comorbidity | 1 | 2018 | 10590 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15948 | 0.050 |
Why?
|
Infant | 1 | 2024 | 36535 | 0.050 |
Why?
|
Drug-Eluting Stents | 2 | 2019 | 681 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26379 | 0.050 |
Why?
|
Phosphatidylcholines | 1 | 2022 | 406 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2022 | 574 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2022 | 386 | 0.040 |
Why?
|
Emigration and Immigration | 1 | 2023 | 406 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2022 | 323 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22291 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2021 | 564 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2661 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2021 | 408 | 0.040 |
Why?
|
United States | 2 | 2024 | 73039 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2023 | 4543 | 0.040 |
Why?
|
Hemostasis | 1 | 2021 | 468 | 0.040 |
Why?
|
Thrombophilia | 1 | 2021 | 308 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.040 |
Why?
|
Virus Internalization | 1 | 2021 | 504 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2024 | 1835 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 416 | 0.030 |
Why?
|
Cephalometry | 1 | 2018 | 380 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54926 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1609 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 893 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10101 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 590 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2021 | 1183 | 0.030 |
Why?
|
Photography | 1 | 2018 | 537 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1798 | 0.030 |
Why?
|
Chick Embryo | 1 | 2016 | 975 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2464 | 0.030 |
Why?
|
Lactones | 1 | 2016 | 316 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15832 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 849 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2019 | 2125 | 0.030 |
Why?
|
Sirolimus | 1 | 2019 | 1540 | 0.020 |
Why?
|
Medication Adherence | 1 | 2023 | 2187 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 810 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2017 | 1162 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3228 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 747 | 0.020 |
Why?
|
Angiography | 1 | 2016 | 1597 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3479 | 0.020 |
Why?
|
Primary Prevention | 1 | 2017 | 1188 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2021 | 4352 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2981 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36743 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9374 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10760 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10632 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9384 | 0.010 |
Why?
|
Depression | 1 | 2024 | 8230 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15454 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20227 | 0.010 |
Why?
|
Animals | 1 | 2016 | 169246 | 0.000 |
Why?
|
Concepts
(264)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_